Abida Khan

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 21

Top Topics

Molecular Docking

Acinetobacter Baumannii

Hiv Infected Patients

Top Venues

Molecules (Basel, Switzerland)

Expert opinion on therapeutic patents

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Tafadzwa Dzinamarira, Mazen M Almehmadi, Ahad Amer Alsaiari, Mamdouh Allahyani, Abdulelah Aljuaid, Abdulaziz Alsharif, Abida Khan, Mehnaz Kamal, Ali A Rabaan, Amal H Alfaraj, Bashayer M AlShehail, Nouf E Alotaibi, Shams M AlShehail, Mohd Imran
Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Mohammed Kanan Alshammari, Eman Yaser Almomen, Kholoud Falah Alshahrani, Shroog Farhan Altwalah, Mehnaz Kamal, May Faiz Al-Twallah, Suheir Hassan Alsanad, Mariam Hassan Al-Batti, Faisal Jarallah Al-Rasheed, Abdulaziz Yousef Alsalamah, Mohammed Bader Alhazza, Faisal Abdu Alasmari, Abida Khan, Mohd Imran
Nano-Enabled Strategies for the Treatment of Lung Cancer: Potential Bottlenecks and Future Perspectives. Biomedicines 11 (2) (2023)
Shuaibu Abdullahi Hudu, Fayig Elmigdadi, Aiman Al Qtaitat, Mazen M Almehmadi, Ahad Amer Alsaiari, Mamdouh Allahyani, Abdulelah Aljuaid, Magdi Mansour Salih, Adel Alghamdi, Mohammad A Alrofaidi, Abida Khan, Mohd Imran
Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need. Journal of clinical medicine 12 (15) (2023)
Mohd Imran, Mohammed Kanan Alshammari, Mandeep Kumar Arora, Amit Kumar Dubey, Sabya Sachi Das, Mehnaz Kamal, Abdulaziz Saad Abdulrahman Alqahtani, Mohammed Ahmed Yahya Sahloly, Ahmed Hammad Alshammari, Hessah Mohammed Alhomam, Aeshah Mousa Mahzari, Abida Khan, Ali A Rabaan, Tafadzwa Dzinamarira
Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects. Biomedicines 11 (2) (2023)
Mohammed Kanan Alshammari, Eman Yaser Almomen, Kholoud Falah Alshahrani, Shroog Farhan Altwalah, Mehnaz Kamal, May Faiz Al-Twallah, Suheir Hassan Alsanad, Mariam Hassan Al-Batti, Faisal Jarallah Al-Rasheed, Abdulaziz Yousef Alsalamah, Mohammed Bader Alhazza, Faisal Abdu Alasmari, Abida Khan, Mohd Imran
Nano-Enabled Strategies for the Treatment of Lung Cancer: Potential Bottlenecks and Future Perspectives. Biomedicines 11 (2) (2023)
Muhammad Sarfraz, Mosab Arafat, Syeda Huma H Zaidi, Lina Eltaib, Muhammad Irfan Siddique, Mehnaz Kamal, Abuzer Ali, Syed Mohammed Basheeruddin Asdaq, Abida Khan, Shams Aaghaz, Mohammed Sanad Alshammari, Mohd Imran
Resveratrol-Laden Nano-Systems in the Cancer Environment: Views and Reviews. Cancers 15 (18) (2023)
Muhammad Sarfraz, Abida Khan, Gaber El-Saber Batiha, Muhammad Furqan Akhtar, Ammara Saleem, Basiru Olaitan Ajiboye, Mehnaz Kamal, Abuzer Ali, Nawaf M Alotaibi, Shams Aaghaz, Muhammad Irfan Siddique, Mohd Imran
Nanotechnology-Based Drug Delivery Approaches of Mangiferin: Promises, Reality and Challenges in Cancer Chemotherapy. Cancers 15 (16) (2023)
Mohammed Kanan Alshammari, Eman Yaser Almomen, Kholoud Falah Alshahrani, Shroog Farhan Altwalah, Mehnaz Kamal, May Faiz Al-Twallah, Suheir Hassan Alsanad, Mariam Hassan Al-Batti, Faisal Jarallah Al-Rasheed, Abdulaziz Yousef Alsalamah, Mohammed Bader Alhazza, Faisal Abdu Alasmari, Abida Khan, Mohd Imran
Nano-Enabled Strategies for the Treatment of Lung Cancer: Potential Bottlenecks and Future Perspectives. Biomedicines 11 (2) (2023)
Tafadzwa Dzinamarira, Mazen M Almehmadi, Ahad Amer Alsaiari, Mamdouh Allahyani, Abdulelah Aljuaid, Abdulaziz Alsharif, Abida Khan, Mehnaz Kamal, Ali A Rabaan, Amal H Alfaraj, Bashayer M AlShehail, Nouf E Alotaibi, Shams M AlShehail, Mohd Imran
Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Tafadzwa Dzinamarira, Mazen M Almehmadi, Ahad Amer Alsaiari, Mamdouh Allahyani, Abdulelah Aljuaid, Abdulaziz Alsharif, Abida Khan, Mehnaz Kamal, Ali A Rabaan, Amal H Alfaraj, Bashayer M AlShehail, Nouf E Alotaibi, Shams M AlShehail, Mohd Imran
Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Mohd Imran, Mohammed Kanan Alshammari, Mandeep Kumar Arora, Amit Kumar Dubey, Sabya Sachi Das, Mehnaz Kamal, Abdulaziz Saad Abdulrahman Alqahtani, Mohammed Ahmed Yahya Sahloly, Ahmed Hammad Alshammari, Hessah Mohammed Alhomam, Aeshah Mousa Mahzari, Abida Khan, Ali A Rabaan, Tafadzwa Dzinamarira
Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects. Biomedicines 11 (2) (2023)
Mohd Imran, Mohammed Kanan Alshammari, Mandeep Kumar Arora, Amit Kumar Dubey, Sabya Sachi Das, Mehnaz Kamal, Abdulaziz Saad Abdulrahman Alqahtani, Mohammed Ahmed Yahya Sahloly, Ahmed Hammad Alshammari, Hessah Mohammed Alhomam, Aeshah Mousa Mahzari, Abida Khan, Ali A Rabaan, Tafadzwa Dzinamarira
Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects. Biomedicines 11 (2) (2023)
Mohd Imran, Shah Alam Khan, Abida Khan, Ahmed Subeh Alshrari, Mahmoud Mudawi Eltahir Mudawi, Mohammed Kanan Alshammari, Aishah Ali Harshan, Noufah Aqeel Alshammari
Small molecules as kinetoplastid specific proteasome inhibitors for leishmaniasis: a patent review from 1998 to 2021. Expert opinion on therapeutic patents 32 (5) (2022)
Mohd Imran, Shah Alam Khan, Abida Khan, Mohammed Kanan Alshammari, Saif M Alkhaldi, Fayez Nafea Alshammari, Mehnaz Kamal, Ozair Alam, Syed Mohammed Basheeruddin Asdaq, A Khuzaim Alzahrani, Shahamah Jomah
Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature. Molecules (Basel, Switzerland) 27 (9) (2022)
Mohd Imran, Ahmed Subeh Alshrari, Mohammad Tauseef, Shah Alam Khan, Shuaibu Abdullahi Hudu, Abida Khan
Mucormycosis medications: a patent review. Expert opinion on therapeutic patents 31 (11) (2021)
Mohd Imran, Mandeep Kumar Arora, Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, Saleh I Alaqel, Mohammed Kanan Alshammari, Mohammed Mansour Alshehri, Ahmed Subeh Alshrari, Alreshidi Mateq Ali, Ahmed Muteb Al-Shammeri, Bushra Dhuhayyan Alhazmi, Aishah Ali Harshan, Md Tauquir Alam, Abida Khan
Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19. Molecules (Basel, Switzerland) 26 (19) (2021)
Mohd Imran, Ahmed Subeh Alshrari, Hamdy Kh Thabet, Abida Khan, Mohammed Afroz Bakht
Synthetic molecules as DprE1 inhibitors: A patent review. Expert opinion on therapeutic patents 31 (8) (2021)
Mohd Imran, Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, Dhanalekshmi Unnikrishnan Meenakshi, Abdulhakeem S Alamri, Walaa F Alsanie, Majid Alhomrani, Yahya Mohzari, Ahmed Alrashed, Mohammed AlMotairi, Eman H Alkhaldi, Abeer K Alorabi, Ahmed Subeh Alshrari, Mohammad Tauseef, Abida Khan, Saleh I Alaqel, Ozair Alam, Mohammed Afroz Bakht
Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Mohd Imran, Md Afroz Bakht, Abida Khan, Md Tauquir Alam, El Hassane Anouar, Mohammed B Alshammari, Noushin Ajmal, Archana Vimal, Awanish Kumar, Yassine Riadi
An Improved Synthesis of Key Intermediate to the Formation of Selected Indolin-2-Ones Derivatives Incorporating Ultrasound and Deep Eutectic Solvent (DES) Blend of Techniques, for Some Biological Activities and Molecular Docking Studies. Molecules (Basel, Switzerland) 25 (5) (2020)
Abida Khan, Anupama Diwan, Hamdy K Thabet, Mohd Imran
Synthesis of novel N-substitutedphenyl-6-oxo-3-phenylpyridazine derivatives as cyclooxygenase-2 inhibitors. Drug development research 81 (5) (2020)
Abida Khan, Anupama Diwan, Hamdy Kh Thabet, Mohd Imran, Md Afroz Bakht
Discovery of Novel Pyridazine-Based Cyclooxygenase-2 Inhibitors with a Promising Gastric Safety Profile. Molecules (Basel, Switzerland) 25 (9) (2020)